HIT Consultant January 23, 2024
Jasmine Pennic

What You Should Know:

Thirona, a pioneer in AI-powered lung analysis, received a major boost for its cutting-edge technology LungQ™ with the U.S. Food and Drug Administration (FDA) 510(k) clearance for its latest update, v3.0.0.

– This FDA clearance paves the way for American hospitals to now harness the software’s advanced capabilities, marking a significant step forward in lung disease diagnosis and treatment.

LungQ 3.0.0: Precision Navigation for Lung Interventions

This latest iteration stands out as one of the few FDA-cleared solutions capable of automatically segmenting and analyzing the intricate landscape of the lungs’ internal anatomy. Its AI prowess goes beyond mere mapping; it identifies key structures like lobes, segments, subsegments, airways, and fissures, allowing for:

  • Detailed tissue...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Provider, Technology
When AI Learns To Lie
Diving into Health IT Policy, Medicare Advantage, and AI in Healthcare
Is AI The Secret Weapon To Help Stop Cyber Attacks?
Inching towards AGI: How reasoning and deep research are expanding AI from statistical prediction to structured problem-solving
How the U.S. is losing ground to China in nuclear fusion, as AI power needs surge

Share This Article